10-2与24-2视野检查检测青光眼中心视野异常的性能比较
本横断面病例对照研究比较了24-2视野中央12个位置推导的PSD(C24-2)与完整10-2视野PSD在检测青光眼中心视野异常中的性能。结论认为两种方法识别的中心视野异常眼数相似,但需进一步研究明确10-2的潜在优势。
要点
- 在95%特异度下,10-2与C24-2的PSD敏感度无显著差异(35.9% vs 35.4%)。
- 两种方法检测的病例一致性高(kappa=0.80),PSD值强相关(R2=0.91)。
- 10-2与24-2识别中心视野异常的眼数相似,但10-2的潜在优势需进一步研究。
核心结论
- 使用PSD值时,10-2与24-2视野检查识别的青光眼或疑似青光眼及高危眼中,中心视野异常的眼数相似。
研究设计与样本
- 横断面病例对照研究,纳入基于掩蔽视盘立体照片分级和/或高眼压(眼压≥22 mmHg)确定的青光眼、疑似青光眼或高危眼作为病例(n=523),健康对照眼(n=107)用于匹配特异度。
主要发现
- 两种方法检测的病例一致性高(kappa=0.80±0.04),PSD值强相关(R2=0.91)。
关键数值与推荐
- 敏感度比较在95%特异度下进行,使用完整10-2和C24-2的PSD值。
- 病例组眼压≥22 mmHg或基于视盘立体照片分级判定为青光眼、疑似青光眼或高危。
临床怎么用
- 在临床中,使用PSD值时10-2与24-2视野检查对中心视野异常的检测性能相似。
- 不应仅凭本研究否定10-2的用途,需进一步研究明确其潜在优势以指导临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To compare the performance of the pattern standard deviation (PSD) values derived from the central 12 locations of the 24-2 visual field test (C24-2) to the entire 10-2 test for detecting central visual field abnormalities in eyes with, suspected of having, or at risk of having glaucoma. DESIGN: Cross-sectional case-control study. METHODS: Eyes with, suspected of having, or at risk of having glaucoma, based on masked grading of optic disc stereophotographs and/or ocular hypertension (intraocular pressure ≥ 22 mm Hg) were included as cases (n = 523). Eyes from healthy participants were included as controls (n = 107) to allow the 2 tests to be compared at matched specificities. The sensitivity to detect cases at 95% specificity using PSD values derived from the entire 10-2 test and C24-2 were compared. RESULTS: The sensitivity of the 10-2 and C24-2 PSD values was not significantly different between the 10-2 and C24-2 at matched specificities (35.9% and 35.4% respectively; P = .900). There was also a substantial agreement between the cases detected by both methods (kappa = 0.80 ± 0.04), and a very strong association between the PSD values from the 2 methods (R2 = 0.91). CONCLUSIONS: 10-2 and 24-2 tests identified a similar number of eyes with, suspected of having, or at risk of having glaucoma as having central visual field abnormalities using PSD values. These findings do not mean that 10-2 tests are not useful, but highlight the need for further studies to determine the potential advantages of 10-2 tests through equivalent comparisons against 24-2 tests to ensure appropriate recommendations are made about its incorporation into the glaucoma standard of care.
引用
- Wu Z, Medeiros FA, Weinreb RN, et al. Performance of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma. Am J Ophthalmol. 2018. PMID: 30099037. doi:10.1016/j.ajo.2018.08.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。